Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LSK Lasik Vision Corp - Previously FVC (First Venture) -- Ignore unavailable to you. Want to Upgrade?

To: Biotechboy13 who wrote (11)	5/7/1999 12:28:00 PM
From: Andrew	Respond to of 30

That was a good deal indeed! Last I heard, it cost US$2k per EYE in the States. I was successful in my order - paid US$2.50.

To: Biotechboy13 who wrote (11)	5/12/1999 10:38:00 AM
From: Andrew	Respond to of 30

NEWS! Monday May 10, 9:09 am Eastern Time Lasik, MedNet won't merge (Full text of press release from Canadian Corporate News) TSE SYMBOL: MDT MAY 10, 1999 Lasik and MedNet Report on Proposed Merger VANCOUVER, BRITISH COLUMBIA--Lasik Vision Corporation (''Lasik'') and MedNet International Ltd. (''MedNet'') today provided updated information on their previously announced (February 5, 1999) proposed merger. The two Companies were unable to come to final terms for the definitive transaction structure and therefore, have decided not to proceed with the previously announced business combination. As a result, Lasik's proposed sale of $4,000,000 principal amount 10 percent secured convertible debentures with MFC Bancorp Ltd. as selling agent will not be proceeding. On behalf of the Board of Directors of LASIK VISION CORPORATION Douglas L. Mason, Director On behalf of the Board of Directors of MEDNET INTERNATIONAL LTD. Jimmy Lee, Chairman The Toronto Stock Exchange, the Vancouver Stock Exchange nor any other regulatory body have reviewed this news release and therefore do not accept responsibility for the adequacy or accuracy of the release. FOR FURTHER INFORMATION PLEASE CONTACT: Lasik Vision Corporation Kelly Lendvoy 1-888-888-9122 (Canada) 1-888-888-9123 (U.S.) or MedNet International Ltd. Rene Randall (604) 683-5767

To: Biotechboy13 who wrote (11)	5/12/1999 10:39:00 AM
From: Andrew	Read Replies (1) \| Respond to of 30

MORE NEWS!! Your thoughts, please... Wednesday May 12, 9:25 am Eastern Time Company Press Release Lasik Vision Moves Ahead With Financing Agreement VANCOUVER, British Columbia--(BUSINESS WIRE)--May 12, 1999--Lasik Vision Corporation (VSE:LSK - news) today announced that the Company has received an extension to the filing deadline for its $15 million convertible debenture offering. Lasik Vision is now proceeding with an agreement with Pacific International Securities Inc. as agent to sell on a proposed private placement of a $15,000,000, 10 percent five-year convertible debenture, as previously announced in a February 5, 1999 news release. The completion of the private placement is subject to acceptance for filing by the Vancouver Stock Exchange. Lasik Vision Corporation CEO, Michael Henderson said that the Company intends to use the proceeds of the $15 million debenture financing to purchase additional equipment and as working capital to support Lasik Vision's expansion plans into the U.S. Based in Vancouver, B.C., Lasik Vision Corporation is Canada's largest operating laser vision correction company. Lasik Vision has already treated tens of thousands of patients in Canada at its centres located in Vancouver, Toronto, Calgary, Montreal, Ottawa, Halifax, Quebec City, Windsor and Winnipeg. With some of the most experienced specialists in North America, Lasik Vision's goal is to provide the best quality patient care and results at the most affordable price for patients. Additional information on the Company may be obtained on the world wide web at www.lasik-vision.com. Statements and/or financial forecasts that are not historical are to be regarded as forward-looking statements, which are subject to risks and uncertainties and could cause actual results to differ materially. Such risks and uncertainties with respect to Lasik Vision's business include but are not limited to: (i) general economic conditions, (ii) limited operating history, (iii) continued industry and public acceptance, (iv) regulatory compliance, (v) potential liability or malpractice claims, (vi) future capital requirements and uncertainty of additional funding and (vii) dependence on key personnel. These forward-looking statements should not be reprinted, reiterated nor considered an inducement for investment. On behalf of the Board of Directors of LASIK VISION CORPORATION Signed, Michael Henderson, CEO The Vancouver Stock Exchange nor any other regulatory body has not reviewed this news release and therefore does not accept responsibility for the adequacy or accuracy of the release. Contact: Lasik Vision Corporation Kelly Lendvoy, 888/888-9122 (Canada) 888/888-9123 (U.S.) World wide web: www.lasik-vision.com